NEW DELHI: Eleven ophthalmic merchandise marketed by Solar Pharma have been withdrawn after the corporate’s distribution arm directed retailers to cease additional provide and withdraw current shares from the commerce channel, in line with a communication accessed by TOI. The July 17 communication instructed distributors to discontinue additional distribution of the merchandise.The merchandise lined are Depopred 2ml, Brinolar (BKC Free), Brinzotim Eye Drops 5ml (BKC Free), Lotepred 5ml, Lotepred 1% Eye Drops 5ml, Lotepred LS 0.2% Eye Drops 5ml, Lotepred T, Nepalact OD Eye Drops 3ml, Nepalact-Z, Toba-F and Nepalact E/D 5ml. These medicines are broadly prescribed for glaucoma, post-operative irritation, allergic eye illnesses and bacterial eye infections.
Share your ideas within the feedback
InsightfulAgreeDisagreeSkepticalConcerningPromisingWorth ReadingBig Improvement
Submit Remark
Be respectful · TOI neighborhood tips
Responding to TOI, a Solar Pharma spokesperson stated: “Now we have initiated a proactive voluntary withdrawal of some ophthalmic merchandise as a matter of considerable precaution. Product high quality and affected person security are essential to us.” The corporate, nonetheless, didn’t specify the rationale for the withdrawal of merchandise or make clear whether or not it was linked to any manufacturing or high quality subject.
